Literature DB >> 1575018

Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease.

D M Mann1, D Jones, P W South, J S Snowden, D Neary.   

Abstract

In two elderly patients with frontal lobe dementia and in two others with progressive aphasia an inverse relationship between the severity of beta protein deposition and the principal pathology of these disorders was noted. Deposition of beta protein occurred only in areas of cortex where functional (viable) neurones were still present and was absent where neuronal decimation had taken place. Such findings suggest that the presence of functional neurones is necessary for beta protein deposition to occur and, therefore, that neurones may be the source of the amyloid protein that is deposited within brain parenchyma not only in these disorders but also in other conditions, particularly Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575018     DOI: 10.1007/bf00713534

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Widespread expression of amyloid beta-protein precursor gene in rat brain.

Authors:  S Mita; E A Schon; J Herbert
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

2.  Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls.

Authors:  F Tagliavini; J Ghiso; W F Timmers; G Giaccone; O Bugiani; B Frangione
Journal:  Lab Invest       Date:  1990-06       Impact factor: 5.662

3.  A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques.

Authors:  D M Mann; A M Brown; D Prinja; D Jones; C A Davies
Journal:  Neuropathol Appl Neurobiol       Date:  1990-02       Impact factor: 8.090

4.  Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.

Authors:  D M Mann; D Jones
Journal:  Neurosci Lett       Date:  1990-02-05       Impact factor: 3.046

5.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

Review 6.  Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Neurobiol Aging       Date:  1989 Sep-Oct       Impact factor: 4.673

7.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

8.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

Authors:  A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

9.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.

Authors:  S Bahmanyar; G A Higgins; D Goldgaber; D A Lewis; J H Morrison; M C Wilson; S K Shankar; D C Gajdusek
Journal:  Science       Date:  1987-07-03       Impact factor: 47.728

10.  Frontal lobe dementia and motor neuron disease.

Authors:  D Neary; J S Snowden; D M Mann; B Northen; P J Goulding; N Macdermott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more
  11 in total

1.  Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

Authors:  J L Holton; J Ghiso; T Lashley; A Rostagno; C J Guerin; G Gibb; H Houlden; H Ayling; L Martinian; B H Anderton; N W Wood; R Vidal; G Plant; B Frangione; T Revesz
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Interaction between prion protein and Aβ amyloid fibrils revisited.

Authors:  Krzysztof Nieznanski; Krystyna Surewicz; Shugui Chen; Hanna Nieznanska; Witold K Surewicz
Journal:  ACS Chem Neurosci       Date:  2014-04-01       Impact factor: 4.418

3.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

4.  Senile plaques in temporal lobe epilepsy.

Authors:  I R Mackenzie; L A Miller
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 5.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

6.  Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Authors:  Peter T Nelson; Gregory A Jicha; Frederick A Schmitt; Huaichen Liu; Daron G Davis; Marta S Mendiondo; Erin L Abner; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2007-12       Impact factor: 3.685

7.  Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease.

Authors:  Yvonne S Davidson; Andrew C Robinson; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol Commun       Date:  2013-08-12       Impact factor: 7.801

Review 8.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

9.  The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.

Authors:  Christina E Murray; Priya Gami-Patel; Eleni Gkanatsiou; Gunnar Brinkmalm; Erik Portelius; Oliver Wirths; Wendy Heywood; Kaj Blennow; Jorge Ghiso; Janice L Holton; Kevin Mills; Henrik Zetterberg; Tamas Revesz; Tammaryn Lashley
Journal:  Acta Neuropathol Commun       Date:  2018-07-20       Impact factor: 7.801

10.  AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease.

Authors:  Tomomi Kiyota; Gang Zhang; Christine M Morrison; Megan E Bosch; Robert A Weir; Yaman Lu; Weiguo Dong; Howard E Gendelman
Journal:  Mol Ther       Date:  2015-07-31       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.